Home » Topics » Conferences

Conferences
RSS

News from FASEB: novel botanical product for treatment of Alzheimer's disease

April 20, 1999

BNP-7787 protects against taxane- and platinum-associated neurotoxicity

April 20, 1999

Further phase I data presented for bizelesin at AACR meeting

April 20, 1999

New compound for BPH in active preclinical development at Merck & Co. and Synaptic

April 20, 1999

New frontiers in gene therapy: treatment of erectile dysfunction

April 20, 1999

Recombinant immunotoxin for hematological malignancies from NCI evaluated in phase I

April 20, 1999

Immunological response to GMK melanoma vaccine examined as part of phase III trial

April 19, 1999

News from FASEB: dermal pharmacology of Dekk-Tec's A-007

April 19, 1999

News from AACR: 9-NC does not require conversion to 9-AC to exert antitumor activity

April 19, 1999

News from FASEB: ETA antagonist with potential in the treatment of pulmonary hypertension

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...